Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from 23andMe Holding ( (MEHCQ) ) is now available.
Chrome Holding Co. and its subsidiaries, collectively known as the Debtors, filed for Chapter 11 bankruptcy on March 23, 2025. On July 14, 2025, they sold most of their assets to TTAM Research Institute for $302.5 million. The Debtors are now working to finalize their Chapter 11 cases with a proposed plan that includes asset sales, such as the Lemonaid Health business, and various claims settlements. The plan’s approval is pending in court, and the company warns that trading its common stock remains speculative during this period.
The most recent analyst rating on (MEHCQ) stock is a Hold with a $8.40 price target. To see the full list of analyst forecasts on 23andMe Holding stock, see the MEHCQ Stock Forecast page.
Spark’s Take on MEHCQ Stock
According to Spark, TipRanks’ AI Analyst, MEHCQ is a Neutral.
23andMe Holding’s overall stock performance is weak, primarily due to significant financial challenges, including declining revenues and persistent net losses. The technical analysis also suggests a bearish trend with no strong momentum to reverse it. The negative valuation metrics further highlight the company’s struggles with profitability. Improvements in financial performance and strategic adjustments to reverse negative trends are critical for enhancing investor confidence.
To see Spark’s full report on MEHCQ stock, click here.
More about 23andMe Holding
Average Trading Volume: 322,687
Technical Sentiment Signal: Sell
Current Market Cap: $103.6M
See more data about MEHCQ stock on TipRanks’ Stock Analysis page.